
endometrial cancer
96
MENTIONS
7
EPISODES
4
PODCASTS
Search complete. 96 mentions across 7 episodes found for "endometrial cancer".
Oct 12, 2026
What is metabolic syndrome?
T
2:01Terry NaturallyHOST
We'll also talk about the keto diet for cancer.
T
2:07Terry NaturallyHOST
Why does it work for cancer? And how does it improve cancer situations? Especially endometrial cancer.
T
2:18Terry NaturallyHOST
Ouch! What about pulled muscles? What can you do about a pulled muscle besides saying ouch? An herb for the day.
T
2:29Terry NaturallyHOST
One of my favorites.
20 MINS LATER
T
22:23Terry NaturallyHOST
The FDA recommends 130 grams, but that's still too high.
T
22:29Terry NaturallyHOST
They found the best results for mental disease, anxiety, anywhere from zero sugar to twenty to forty grams of carbohydrates daily.
T
22:45Terry NaturallyHOST
Now, the keto diet, particularly for endometrial cancer.
T
22:52Terry NaturallyHOST
So what is this cancer, endometrial cancer? Endometrial cancer occurs when a tumor forms in the inner lining of the uterus.
Ovarian and Endometrial Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
S
0:13Stephen DiversMODERATOR
We are now in module three.
S
0:15Stephen DiversMODERATOR
We're going to be discussing ovarian and endometrial cancer.
S
0:18Stephen DiversMODERATOR
We're blessed to have Shannon Weston join us here today.
S
0:23Stephen DiversMODERATOR
Shannon is from the University of Texas MD Anderson Cancer Center, where she's a medical director for the Gynecologic Oncology Center.
S
0:44Stephen DiversMODERATOR
So 639 ovarian cancer patients, limited enrollment in clinical trial.
S
0:48Stephen DiversMODERATOR
We've got to do better there.
S
0:50Stephen DiversMODERATOR
Endometrial cancer, similar numbers.
S
0:53Stephen DiversMODERATOR
Again, small enrollment in clinical trials.
Ovarian and Endometrial Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
S
0:13Stephen DiversMODERATOR
We are now in module three.
S
0:15Stephen DiversMODERATOR
We're gonna be discussing ovarian and endometrial cancer.
S
0:18Stephen DiversMODERATOR
We're blessed to have Shannon Weston join us here today.
S
0:23Stephen DiversMODERATOR
Shannon is, uh, from the University of Texas MD Anderson Cancer Center, um, where, um, she's a medical director for the Gynecologic Oncology Center.
S
0:43Stephen DiversMODERATOR
So, uh, six hundred and thirty-nine ovarian cancer patients, um, limited enrollment clinical trial.
S
0:48Stephen DiversMODERATOR
We gotta do better there.
S
0:50Stephen DiversMODERATOR
Uh, endometrial cancer, similar numbers.
S
0:53Stephen DiversMODERATOR
Um, again, small enrollment in clinical trials.
Ovarian and Endometrial Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
S
0:13Stephen Fred DiversMODERATOR
We are now in Module 3.
S
0:15Stephen Fred DiversMODERATOR
We're going to be discussing ovarian and endometrial cancer.
S
0:18Stephen Fred DiversMODERATOR
We're blessed to have Shannon Weston join us here today.
S
0:23Stephen Fred DiversMODERATOR
Shannon is from the University of Texas MD Anderson Cancer Center, where she's a medical director for the Gynecologic Oncology Center.
S
0:43Stephen Fred DiversMODERATOR
So 639 ovarian cancer patients, limited enrollment clinical trial.
S
0:48Stephen Fred DiversMODERATOR
We've got to do better there.
S
0:50Stephen Fred DiversMODERATOR
Endometrial cancer, similar numbers.
S
0:53Stephen Fred DiversMODERATOR
Again, small enrollment in clinical trials.
Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
N
0:39Neil LoveHOST
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
N
0:49Neil LoveHOST
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
N
0:57Neil LoveHOST
I'm particularly excited about what happened in endometrial cancer.
N
1:00Neil LoveHOST
To me, it was really a landmark moment, but we'll get into that in a second.
N
1:04Neil LoveHOST
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
N
5:10Neil LoveHOST
There's going to be a big presentation at the ESMO meeting on SAC-TMT, atrope 2 ADC.
N
5:16Neil LoveHOST
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
N
5:27Neil LoveHOST
All right, so let's start out with endometrial cancer.
Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
N
0:39Neil LoveHOST
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
N
0:49Neil LoveHOST
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
N
0:57Neil LoveHOST
I'm particularly excited about what happened in endometrial cancer.
N
1:00Neil LoveHOST
To me, it was really a landmark moment, but we'll get into that in a second.
N
1:04Neil LoveHOST
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
N
5:10Neil LoveHOST
There's going to be a big presentation at the ESMO meeting on SAC-TMT at Trope 2 ADC.
N
5:16Neil LoveHOST
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
N
5:27Neil LoveHOST
All right, so let's start out with endometrial cancer.
Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
N
0:39Neil LoveHOST
As in pretty much all of our programs, we will be discussing the use of non-FDA-approved agents and regimens, so check out package inserts for more information.
N
0:49Neil LoveHOST
So basically, we're going to start out talking about endometrial cancer, then we'll get into ovarian cancer and cervical cancer.
N
0:57Neil LoveHOST
I'm particularly excited about what happened in endometrial cancer.
N
1:00Neil LoveHOST
To me, it was really a landmark moment, but we'll get into that in a second.
N
1:04Neil LoveHOST
But I had to bring up first, before we get started, not related to ASCO, just something that I wanted to ask you all about.
N
5:10Neil LoveHOST
There's going to be a big presentation at the ESMO meeting on SAC-TMT at Trope 2 ADC.
N
5:16Neil LoveHOST
But anyhow, just pointing out to you, there was a really cool education program looking at ADCs in all three of the tumors that we're going to be talking about tonight.
N
5:27Neil LoveHOST
All right, so let's start out with endometrial cancer.